Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jonas

Stroke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Stroke|November 1, 1986
IMPS (intact months of patient survival): an analysis of the results of carotid endarterectomyS Jonas
Stroke|September 1, 1985
Asymptomatic carotid stenosisS Jonas
Stroke|November 1, 1986
A proposed method for using a reimbursement moratorium to encourage recruitment for a randomized study of carotid endarterectomyS Jonas
Stroke|August 1, 1988
Anticoagulant therapy in cerebrovascular disease: review and meta-analysisS Jonas
Stroke|May 1, 1996
Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 gangliosideG Grieco, M d'Hollosy, A T Culliford, et al.
Stroke|May 1, 1994
Prophylactic neuroprotection for cerebral ischemiaM Fisher, S Jonas, R L Sacco, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Stroke|November 1, 1986
IMPS (intact months of patient survival): an analysis of the results of carotid endarterectomyS Jonas
Stroke|September 1, 1985
Asymptomatic carotid stenosisS Jonas
Stroke|November 1, 1986
A proposed method for using a reimbursement moratorium to encourage recruitment for a randomized study of carotid endarterectomyS Jonas
Stroke|August 1, 1988
Anticoagulant therapy in cerebrovascular disease: review and meta-analysisS Jonas
Stroke|May 1, 1996
Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 gangliosideG Grieco, M d'Hollosy, A T Culliford, et al.
Stroke|May 1, 1994
Prophylactic neuroprotection for cerebral ischemiaM Fisher, S Jonas, R L Sacco, et al.
Pageof 1